Literature DB >> 22130610

Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all.

Feliciano Protasi1, Cecilia Paolini, Marta Canato, Carlo Reggiani, Marco Quarta.   

Abstract

Calsequestrin type-1 (CASQ1), the main sarcoplasmic reticulum (SR) Ca(2+) binding protein, plays a dual role in skeletal fibers: a) it provides a large pool of rapidly-releasable Ca(2+) during excitation-contraction (EC) coupling; and b) it modulates the activity of ryanodine receptors (RYRs), the SR Ca(2+) release channels. We have generated a mouse lacking CASQ1 in order to further characterize the role of CASQ1 in skeletal muscle. Contrary to initial expectations, CASQ1 ablation is compatible with normal motor activity, in spite of moderate muscle atrophy. However, CASQ1 deficiency results in profound remodeling of the EC coupling apparatus: shrinkage of junctional SR lumen; proliferation of SR/transverse-tubule contacts; and increased density of RYRs. While force development during a twitch is preserved, it is nevertheless characterized by a prolonged time course, likely reflecting impaired Ca(2+) re-uptake by the SR. Finally, lack of CASQ1 also results in increased rate of SR Ca(2+) depletion and inability of muscle to sustain tension during a prolonged tetani. All modifications are more pronounced (or only found) in fast-twitch extensor digitorum longus muscle compared to slow-twitch soleus muscle, likely because the latter expresses higher amounts of calsequestrin type-2 (CASQ2). Surprisingly, male CASQ1-null mice also exhibit a marked increased rate of spontaneous mortality suggestive of a stress-induced phenotype. Consistent with this idea, CASQ1-null mice exhibit an increased susceptibility to undergo a hypermetabolic syndrome characterized by whole body contractures, rhabdomyolysis, hyperthermia and sudden death in response to halothane- and heat-exposure, a phenotype remarkably similar to human malignant hyperthermia and environmental heat-stroke. The latter findings validate the CASQ1 gene as a candidate for linkage analysis in human muscle disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130610     DOI: 10.1007/s10974-011-9277-2

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  100 in total

1.  Surface plasmon resonance studies prove the interaction of skeletal muscle sarcoplasmic reticular Ca(2+) release channel/ryanodine receptor with calsequestrin.

Authors:  A Herzog; C Szegedi; I Jona; F W Herberg; M Varsanyi
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

2.  Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization.

Authors:  HaJeung Park; Il Yeong Park; EunJung Kim; Buhyun Youn; Kelly Fields; A Keith Dunker; ChulHee Kang
Journal:  J Biol Chem       Date:  2004-02-10       Impact factor: 5.157

3.  Ultra-rapid activation and deactivation of store-operated Ca(2+) entry in skeletal muscle.

Authors:  Joshua N Edwards; Robyn M Murphy; Tanya R Cully; Frederic von Wegner; Oliver Friedrich; Bradley S Launikonis
Journal:  Cell Calcium       Date:  2010-05       Impact factor: 6.817

Review 4.  Mutations in RYR1 in malignant hyperthermia and central core disease.

Authors:  Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopkins
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

5.  Isolation of a calcium-sequestering protein from sarcoplasmic reticulum.

Authors:  D H MacLennan; P T Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

6.  Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glycoprotein.

Authors:  K P Campbell; D H MacLennan; A O Jorgensen; M C Mintzer
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

7.  Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.

Authors:  Tianzhong Yang; Joyce Riehl; Eric Esteve; Klaus I Matthaei; Samuel Goth; Paul D Allen; Isaac N Pessah; José R Lopez
Journal:  Anesthesiology       Date:  2006-12       Impact factor: 7.892

8.  Structural alterations in cardiac calcium release units resulting from overexpression of junctin.

Authors:  L Zhang; C Franzini-Armstrong; V Ramesh; L R Jones
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

9.  The structure of calsequestrin in triads of vertebrate skeletal muscle: a deep-etch study.

Authors:  C Franzini-Armstrong; L J Kenney; E Varriano-Marston
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

10.  Dantrolene and heatstroke: a good molecule applied in an unsuitable situation.

Authors:  Pierre Hausfater
Journal:  Crit Care       Date:  2004-09-03       Impact factor: 9.097

View more
  20 in total

1.  Dynamic measurement of the calcium buffering properties of the sarcoplasmic reticulum in mouse skeletal muscle.

Authors:  Carlo Manno; Monika Sztretye; Lourdes Figueroa; Paul D Allen; Eduardo Ríos
Journal:  J Physiol       Date:  2012-11-12       Impact factor: 5.182

2.  Antioxidants protect calsequestrin-1 knockout mice from halothane- and heat-induced sudden death.

Authors:  Antonio Michelucci; Cecilia Paolini; Marta Canato; Lan Wei-Lapierre; Laura Pietrangelo; Alessandro De Marco; Carlo Reggiani; Robert T Dirksen; Feliciano Protasi
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

3.  Altered Ca2+ concentration, permeability and buffering in the myofibre Ca2+ store of a mouse model of malignant hyperthermia.

Authors:  Carlo Manno; Lourdes Figueroa; Leandro Royer; Sandrine Pouvreau; Chang Seok Lee; Pompeo Volpe; Alessandra Nori; Jingsong Zhou; Gerhard Meissner; Susan L Hamilton; Eduardo Ríos
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

4.  A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates.

Authors:  Daniela Rossi; Bianca Vezzani; Lucia Galli; Cecilia Paolini; Luana Toniolo; Enrico Pierantozzi; Simone Spinozzi; Virginia Barone; Elena Pegoraro; Luca Bello; Giovanna Cenacchi; Gaetano Vattemi; Giuliano Tomelleri; Giulia Ricci; Gabriele Siciliano; Feliciano Protasi; Carlo Reggiani; Vincenzo Sorrentino
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

5.  Oxidative stress, mitochondrial damage, and cores in muscle from calsequestrin-1 knockout mice.

Authors:  Cecilia Paolini; Marco Quarta; Lan Wei-LaPierre; Antonio Michelucci; Alessandra Nori; Carlo Reggiani; Robert T Dirksen; Feliciano Protasi
Journal:  Skelet Muscle       Date:  2015-04-18       Impact factor: 4.912

Review 6.  The disorders of the calcium release unit of skeletal muscles: what have we learned from mouse models?

Authors:  Marta Canato; Paola Capitanio; Carlo Reggiani; Lina Cancellara
Journal:  J Muscle Res Cell Motil       Date:  2014-11-26       Impact factor: 2.698

Review 7.  Calsequestrin, a key protein in striated muscle health and disease.

Authors:  Daniela Rossi; Alessandra Gamberucci; Enrico Pierantozzi; Caterina Amato; Loredana Migliore; Vincenzo Sorrentino
Journal:  J Muscle Res Cell Motil       Date:  2020-06-02       Impact factor: 2.698

Review 8.  Improper Remodeling of Organelles Deputed to Ca2+ Handling and Aerobic ATP Production Underlies Muscle Dysfunction in Ageing.

Authors:  Feliciano Protasi; Laura Pietrangelo; Simona Boncompagni
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

9.  Functional and structural characterization of a eurytolerant calsequestrin from the intertidal teleost Fundulus heteroclitus.

Authors:  A Carl Whittington; Tatyana E Nienow; Christi L Whittington; Timothy J Fort; Theresa J Grove
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Malignant hyperthermia: a review.

Authors:  Henry Rosenberg; Neil Pollock; Anja Schiemann; Terasa Bulger; Kathryn Stowell
Journal:  Orphanet J Rare Dis       Date:  2015-08-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.